SCHEMBL1160143

SCHEMBL1160143

O=C(NC1CN2CCC1CC2)c1cccc2c1CCCC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1159851 1.00
SCHEMBL9443124 1.00
SCHEMBL7270865 0.99
SCHEMBL7278139 0.98 HTR3A (0.53)
SCHEMBL7270771 0.98 HTR3A (0.53)
SCHEMBL9443039 0.98 HTR3A (0.53)
SCHEMBL7276197 0.87 HTR3E (0.49)
SCHEMBL8084193 0.85 CHRNA7 (0.42)
SCHEMBL7279707 0.85 HTR3E (0.49)
SCHEMBL7269201 0.84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8614225-B2 Process for the purification of palonosetron or its salt DR. REDDY'S LABORATORIES LIMITED (IN) 2013-12-24 US disclosed
WO-2011013095-A1 PROCESSES FOR THE PREPARATION OF PALONOSETRON RANBAXY LABORATORIES LIMITED (IN) 2011-02-03 WO disclosed
US-20080058367-A1 PROCESS FOR THE PURIFICATION OF PALONOSETRON OR ITS SALT DR. REDDY'S LABORATORIES, INC. 2008-03-06 US disclosed
EP-0430190-B1 New tricyclic compounds SYNTEX INC (US) 1995-07-05 EP disclosed
US-5202333-A Tricyclic 5-HT3 receptor antagonists SYNTEX (U.S.A.) INC. (US) 1993-04-13 US disclosed
EP-0430190-A2 New tricyclic compounds SYNTEX (U.S.A.) INC. (US) 1991-06-05 EP disclosed